Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients-Reference-Cited by-同舟云学术

Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients

Published:2015-03-30 Issue:16 Volume:6 Page:14374-14384
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bagdonaite Ieva¹²,Wandall Hans H.²,Litvinov Ivan V.³,Nastasi Claudia¹,Becker Jürgen C.⁴,Dabelsteen Sally⁵,Geisler Carsten¹,Bonefeld Charlotte M.¹,Zhang Qian⁶,Wasik Mariusz A.⁶,Zhou Youwen⁷,Sasseville Denis³,Ødum Niels¹,Woetmann Anders¹

Affiliation:

1. Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

2. Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark

3. Division of Dermatology, McGill University Health Centre, Montreal, Quebec, Canada

4. General Dermatology, Medical University of Graz, Austria

5. Department of Oral Medicine and Pathology, School of Dentistry, University of Copenhagen, Copenhagen, Denmark

6. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, USA

7. Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases;Cancers;2023-02-28

2. Genome-wide identification of alternative splicing associated with histone deacetylase inhibitor in cutaneous T-cell lymphomas;Frontiers in Genetics;2022-09-06

3. Recent Progress in Clinical Development of Therapeutic Antibodies Targeting Glycan-Binding Proteins;Current Drug Targets;2018-08-09

4. Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2017-10